A spokesperson for the company noted that gastroparesis is a known risk for people with diabetes and that "patient safety is of utmost importance to Novo Nordisk." Gastroparesis is not mentioned in the prescribing information for Ozempic or Wegovy, but delayed gastric emptying is mentioned for each drug
Teresa Sellinger Cardiology | July 28, 2026 New data suggest the benefits of a liberal transfusion strategy may outweigh the increased risk for HF
Strinic D, Belosic Halle Z, Luetic K, Nedic A, Petrovic I, Sucic M, Zivanovic Posilovic G, Balenovic D, Strbe S, Udovicic M, Drmic D, Stupnisek M, Lovric Bencic M, Seiwerth S, Sikiric P
Judge Marston utilizes a streamlined structure to handle these unique injury claims efficiently and separately from the GI injuries
The molecule glutathione, known as the mother of all antioxidants, has been connected to several health-related advantages